The Neurofibromatosis Network is delighted to bring you our new science column, The Network Edge, written by science writer Kim Hunter-Schaedle, PhD, providing a summary of recent highlights from NF research and clinical trials. The Network, through advocacy on Capitol Hill and direct funding of research, plays a central role in progress toward a cure.
CONTRIBUTE TO KEEP NF RESEARCH FUNDED
Every three months The Network Edge will bring you the latest research news as compiled by science writer, Kim Hunter-Schaedle, PhD. The goal is to keep you abreast of advancements in treatment and clinical care for all forms of NF.
The Network Edge is presented in bite-sized pieces, allowing you to easily find and focus on those topics of most interest to you, whether it is NF1 learning disabilities studies, NF2 clinical trial updates or schwannomatosis news.
The Network Edge Contents:
1. NF1 Clinical Trials
2. NF2 Clinical Trials
3. NF1 Clinical Management
4. NF2 Clinical Management
5. NF1 Learning Disabilities
6. NF1 Bony Abnormalities
7. Heart and Blood Vessel Abnormalities in NF1
8. Other Clinical Features of NF1
9. Schwannomatosis Update
10. What’s New in NF2 Biology?
11. What’s New in NF1 Biology?
12. Legius Syndrome Update
The Network Edge Contents:
1. CDMRP NFRP – A Critical Funder of NF Research
2. A Focus on NF1 Malignant Peripheral Nerve Sheath Tumors
3. NF2 Clinical Management Updates
4. NF1 Learning Disabilities: News from the Clinic and the Bench
5. NF1 Clinical Management Updates
6. What’s New in NF2 Biology?
7. Heart and Blood Vessel Abnormalities in NF1: New Findings
8. What’s New in NF1 Biology?
9. NF1 Bony Abnormalities Update
10. The Evolving Link Between NF and Cancer
VOLUME 1, FALL 2012
The Network Edge Contents:
1. Impact of the Neurofibromatosis Network on Federal NF Research Funding
2. CDMRP NFRP Clinical Trials Network Expands
3. NF1 Clinical Trials
4. NF1 Clinical Management
5. NF2 Clinical Trials
6. NF2 Clinical Management
7. NF1 Learning Disabilities
8. NF1 Bony Abnormalities
9. Schwannomatosis Update
10. Increased Breast Cancer Risk in NF1
11. Other Clinical Features of NF1
12. What’s New in NF1 Biology and Drug Targets?
13. What’s New in NF2 Biology and Drug Targets?
14. Legius Syndrome Update